Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G antigen 12F (GAGE12F) is a member of the GAGE family of cancer/testis antigens—primate-specific proteins normally restricted to germ cells, but aberrantly expressed in a broad spectrum of cancers[2][5]. GAGE12F enhances tumor cell survival by promoting anti-apoptotic mechanisms and is linked to increased cell migration, invasion, and clonogenic survival, implicating it in cancer progression and metastasis[2][4]. The protein may modulate gene expression via chromatin association, suggesting a regulatory function in both germ and cancer cells[2]. Due to its restricted normal expression and widespread tumor expression, GAGE12F is considered a promising therapeutic target and a potential biomarker in oncology[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G antigen 12F (GAGE12F).